Safety of live attenuated varicella-zoster vaccine in patients with underlying illnesses compared with healthy adults: a prospective cohort study

BACKGROUND: In Japan, freeze-dried live attenuated varicella-zoster vaccine is available for adults aged ≥50 years to prevent herpes zoster. However, limited evidence has been accumulated regarding vaccine safety for patients with underlying illnesses, who have been considered as the high-risk group...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohfuji, Satoko, Ito, Kazuya, Inoue, Megumi, Ishibashi, Motoki, Kumashiro, Hiroko, Hirota, Yoshio, Kayano, Eiji, Ota, Naoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350288/
https://www.ncbi.nlm.nih.gov/pubmed/30691396
http://dx.doi.org/10.1186/s12879-019-3719-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350288/
https://www.ncbi.nlm.nih.gov/pubmed/30691396
http://dx.doi.org/10.1186/s12879-019-3719-7

Ejemplares similares